Boston Scientific Corporation

BSX | NYSE

$43.24

-$0.10 (-0.23%)

Sep 21, 2026, 12:50 PM ET · Market open

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Revenue	20.07B	16.75B	14.24B	12.68B	11.89B	9.91B
Cost of Revenue	6.22B	6.48B	5.41B	4.97B	4.43B	4.34B
Gross Profit	13.85B	10.27B	8.83B	7.71B	7.46B	5.58B
Operating Income	3.97B	2.64B	2.18B	1.82B	1.92B	601M
Interest Income	n/a	107M	22M	10M	4M	3M
Pretax Income	3.39B	2.28B	1.99B	1.14B	1.08B	-79M
Net Income	2.89B	1.85B	1.59B	698M	1.04B	-82M
Selling & General & Admin	6.89B	5.98B	5.19B	4.52B	4.29B	3.79B
Research & Development	2.05B	1.62B	1.41B	1.32B	1.2B	1.14B
Other Expenses	943M	33M	46M	47M	49M	45M
Operating Expenses	9.88B	7.63B	6.65B	5.89B	5.54B	4.98B
Interest Expense	349M	387M	272M	464M	349M	468M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	16.1B	14.11B	12.06B	10.86B	9.97B	9.31B
Income Tax Expense	493M	436M	393M	443M	36M	2M
Shares Outstanding (Basic)	1.48B	1.47B	1.45B	1.43B	1.42B	1.42B
Shares Outstanding (Diluted)	1.49B	1.49B	1.46B	1.44B	1.43B	1.42B
EPS (Basic)	1.96	1.26	1.08	0.45	0.69	-0.08
EPS (Diluted)	1.94	1.25	1.07	0.45	0.69	-0.08
EBITDA	5.1B	3.94B	3.45B	2.74B	2.52B	1.51B
EBIT	3.73B	2.67B	2.26B	1.61B	1.43B	389M
Depreciation & Amortization	1.37B	1.27B	1.2B	1.14B	1.09B	1.12B